Carbarsone
Risk Factor: D
Class: ANTI-INFECTIVES
/ Amebicides
Contents of this page:
Fetal Risk Summary
Breast Feeding Summary
References
Questions and Answers
Fetal Risk Summary
No reports linking the use of carbarsone with congenital defects have been located. However, carbarsone contains approximately 29% arsenic, which has been associated with lesions of the central nervous system (1). In view of potential tissue accumulation and reported fetal fatalities secondary to arsenic poisonings, carbarsone is not recommended during pregnancy (1,2).
Breast Feeding Summary
No data are available.
References
- Arnold W. Morphologic und pathogenese der Salvarsan-schadigungen des zentralnervensystems. Virchows Arch (Pathol Anat) 1944;311:1.
-
Lugo G, Cassady G, Palmisano P. Acute maternal arsenic intoxication with neonatal death. Am J Dis Child 1969;117:328.
